14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $141.98 $159.34 Thursday, 25th Apr 2024 ALNY stock ended at $143.71. This is 0.0626% less than the trading day before Wednesday, 24th Apr 2024. During the day the stock fluctuated 2.67% from a day low at $141.98 to a day high of $145.77.
90 days $141.98 $184.29
52 weeks $141.98 $218.88

Historical Alnylam Pharmaceuticals prices

Date Open High Low Close Volume
Dec 07, 2020 $129.74 $130.67 $126.00 $126.81 300 881
Dec 04, 2020 $130.62 $132.07 $127.25 $129.56 320 585
Dec 03, 2020 $130.00 $132.87 $129.68 $131.17 299 558
Dec 02, 2020 $131.92 $131.92 $127.70 $129.47 356 135
Dec 01, 2020 $130.78 $134.45 $130.65 $132.27 434 773
Nov 30, 2020 $130.31 $132.26 $129.04 $129.91 776 219
Nov 27, 2020 $125.88 $130.21 $125.64 $129.86 262 289
Nov 25, 2020 $127.43 $128.00 $123.68 $125.45 506 782
Nov 24, 2020 $125.69 $128.00 $123.03 $125.66 872 388
Nov 23, 2020 $125.00 $125.50 $120.83 $123.02 493 614
Nov 20, 2020 $123.82 $125.31 $122.92 $124.70 418 027
Nov 19, 2020 $126.62 $126.62 $122.66 $123.81 689 830
Nov 18, 2020 $130.00 $130.23 $125.04 $125.45 676 964
Nov 17, 2020 $130.92 $131.04 $127.72 $129.30 391 355
Nov 16, 2020 $136.01 $136.01 $128.51 $131.05 463 379
Nov 13, 2020 $133.35 $136.67 $132.62 $135.51 722 292
Nov 12, 2020 $129.74 $133.80 $129.74 $132.44 471 089
Nov 11, 2020 $126.62 $130.69 $123.15 $129.09 740 376
Nov 10, 2020 $127.20 $127.64 $124.58 $125.05 844 092
Nov 09, 2020 $133.62 $134.67 $126.66 $127.48 604 514
Nov 06, 2020 $136.03 $137.84 $126.23 $130.73 956 969
Nov 05, 2020 $143.56 $144.63 $136.33 $137.86 740 853
Nov 04, 2020 $133.42 $140.84 $132.47 $139.49 879 964
Nov 03, 2020 $125.00 $130.43 $125.00 $129.05 360 182
Nov 02, 2020 $124.36 $126.23 $122.00 $124.91 479 820
Click to get the best stock tips daily for free!

About Alnylam Pharmaceuticals

Alnylam Pharmaceuticals Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system (CNS)/ocular diseases. Its marketed products include ONPATTRO (patisiran), a lipid complex injection f... ALNY Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT